Serum peak sulfamethoxazole concentrations demonstrate difficulty in achieving a target range: a retrospective cohort study.

Dao, Bao D; Barreto, Jason N; Wolf, Robert C; Dierkhising, Ross A; Plevak, Matthew F; Tosh, Pritish K

Dao, Bao D; Barreto, Jason N; Wolf, Robert C; Dierkhising, Ross A; Plevak, Matthew F; Tosh, Pritish K.

Afiliação

Dao BD; Department of Pharmacy Services, Mayo Clinic, Rochester, Minnesota ; Current affiliation: Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California.
Barreto JN; Department of Pharmacy Services, Mayo Clinic, Rochester, Minnesota.
Wolf RC; Department of Pharmacy Services, Mayo Clinic, Rochester, Minnesota.
Dierkhising RA; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Plevak MF; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Tosh PK; Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

Curr Ther Res Clin Exp ; 76: 104-9, 2014 Dec.

Article em En | MEDLINE | ID: mdl-25408788

Palavras-chave

Serum peak concentration; Sulfamethoxazole; Therapeutic drug monitoring; Trimethoprim

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google